Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 12:47 PM
Ignite Modification Date:
2025-12-24 @ 12:47 PM
NCT ID:
NCT04889261
Eligibility Criteria:
Inclusion Criteria:
1. Diagnostic confirmation of SARS-CoV-2 infection by positive result in at least one test:
* Rapid nasopharyngeal smear antigen test.
* PCR smear or nasopharyngeal aspirate.
* Sputum PCR.
* PCR of bronchoalveolar lavage.
* Positive IgM in the serology for SARS-CoV2
2. Hospitalization for COVID-19 pneumonia
3. More than 5 days from the date of onset of symptoms (this criterion can be met during hospitalization).
4. Elevated D-dimer, by any of the following criteria:
* DD\> 500 ng/ml; In the case of patients over 50 years of age, the DD cut-off point adjusted for age (age x 10) will be applied.
* With the DDU measurement, the cut-off point is 250 mg/dl (instead of 500) and the adjustments for age in those over 50 years are made by multiplying the age x 5 (instead of x 10).
Exclusion Criteria:
1. Pregnancy.
2. Age \<18 years.
3. Hemodynamic instability: SBP \<90 mmHg or vasopressors to achieve ≥ 90 mmHg.
4. Contraindication for performing CT angiography:
* Severe kidney failure (GFR \<30)
* Allergy to iodinated contrasts.
* Intolerance to decubitus.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT04889261
Study Brief:
Protocol Section:
NCT04889261